| Jun 18 |
IceCure Medical to Provide Overview and Share Recent Progress at Northland Capital Markets Virtual Growth Conference on June 25, 2024
|
| Jun 12 |
Positive Data from IceCure's Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function
|
| Jun 4 |
IceCure Medical (ICCM) Moves to Buy: Rationale Behind the Upgrade
|
| Jun 4 |
FDA to Convene Advisory Panel for Review of IceCure's De Novo Marketing Clearance Request for ProSense®, Decision Expected Early 2025; Aligns with Commercial Readiness Plan
|
| May 28 |
IceCure Medical Ltd (ICCM) Q1 2024 Earnings Call Transcript
|
| May 28 |
IceCure Medical GAAP EPS of -$0.08 in-line, revenue of $0.74M misses by $0.14M
|
| May 28 |
IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in First Quarter of 2024
|
| May 21 |
IceCure Medical to Report First Quarter 2024 Financial & Operational Results on May 28, 2024
|
| May 20 |
IceCure Medical to Highlight Key Achievements and Provide Business Overview at A.G.P. / Alliance Global Partners' Virtual Healthcare Company Showcase
|
| May 14 |
Here's Why It's Unlikely That IceCure Medical Ltd's (NASDAQ:ICCM) CEO Will See A Pay Rise This Year
|
